Amicogen Valuation
| 092040 Stock | KRW 3,650 25.00 0.69% |
At this time, the firm appears to be overvalued. Amicogen shows a prevailing Real Value of W3243.45 per share. The current price of the firm is W3650.0. Our model approximates the value of Amicogen from analyzing the firm fundamentals such as Return On Equity of -21.03, current valuation of 808.14 B, and Profit Margin of 0.32 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amicogen's price fluctuation is very steady at this time. Calculation of the real value of Amicogen is based on 3 months time horizon. Increasing Amicogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Amicogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amicogen Stock. However, Amicogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3650.0 | Real 3243.45 | Hype 3650.0 | Naive 3262.61 |
The real value of Amicogen Stock, also known as its intrinsic value, is the underlying worth of Amicogen Company, which is reflected in its stock price. It is based on Amicogen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Amicogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Amicogen helps investors to forecast how Amicogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amicogen more accurately as focusing exclusively on Amicogen's fundamentals will not take into account other important factors: Amicogen Total Value Analysis
Amicogen is presently forecasted to have takeover price of 808.14 B with market capitalization of 373.66 B, debt of 8.21 B, and cash on hands of 26.89 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Amicogen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
808.14 B | 373.66 B | 8.21 B | 26.89 B |
Amicogen Investor Information
About 16.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 127.51. Amicogen had not issued any dividends in recent years. The entity had 2:1 split on the 2nd of April 2018. Based on the analysis of Amicogen's profitability, liquidity, and operating efficiency, Amicogen is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Amicogen Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Amicogen suggests not a very effective usage of assets in March.Amicogen Ownership Allocation
Amicogen holds a total of 19.19 Million outstanding shares. Amicogen shows 16.42 percent of its outstanding shares held by insiders and 8.78 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Amicogen Profitability Analysis
The company reported the revenue of 124.88 B. Net Income was 4.74 B with profit before overhead, payroll, taxes, and interest of 44.55 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amicogen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amicogen and how it compares across the competition.
About Amicogen Valuation
The stock valuation mechanism determines Amicogen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Amicogen. We calculate exposure to Amicogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amicogen's related companies.Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company was founded in 2000 and is headquartered in Jinju, South Korea. Amicogen is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Amicogen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amicogen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amicogen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amicogen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amicogen's revenue streams: Identify Amicogen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amicogen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amicogen's growth potential: Evaluate Amicogen's management, business model, and growth potential.
- Determine Amicogen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amicogen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Amicogen Stock analysis
When running Amicogen's price analysis, check to measure Amicogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicogen is operating at the current time. Most of Amicogen's value examination focuses on studying past and present price action to predict the probability of Amicogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicogen's price. Additionally, you may evaluate how the addition of Amicogen to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |